From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: The burden of alcohol-related complications is considerable, particularly alcohol-associated liver disease and alcohol use disorder (AUD). However, there are deficiencies in comprehensive epidemiological research focusing on these issues, especially among young women who display higher susceptibility to such complications compared with their male counterparts. We thus aimed to determine the global burden of these conditions in this vulnerable group. METHODS: Leveraging data from the Global Burden of Disease Study 2019, we analyzed the prevalence, mortality, and disability-adjusted life years of alcohol-associated cirrhosis (AC), liver cancer from alcohol, and AUD in young women. The findings were categorized by region, nation, and sociodemographic index. RESULTS: The highest age-standardized prevalence rates were observed in AUD (895.96 [95% uncertainty interval (UI) 722.6–1,103.58]), followed by AC (65.33 [95% UI 48.37–86.49]) and liver cancer from alcohol (0.13 [95% UI 0.09–0.19]) per 100,000 people. The highest age-standardized mortality rates were observed in AC (0.75 [95% UI 0.55–0.97]), followed by AUD (0.48 [95% UI 0.43–0.53]) and liver cancer from alcohol (0.06 [95% UI 0.04–0.09]). The highest burdens of AC and AUD were observed in Central Europe, whereas the high-income Asia Pacific had the highest burden of liver cancer from alcohol. DISCUSSION: Throughout the past decade, the trend of AUD varied among regions while the impact of alcohol-associated liver disease has increased, requiring urgent public health strategy to mitigate these complications, particularly in female patients in Europe and the Asia-Pacific region.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Degenhardt, L., Charlson, F., Ferrari, A., Santomauro, D., Erskine, H., Mantilla-Herrara, A., Whiteford, H., Leung, J., Naghavi, M., Griswold, M., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30337-7 · Cited by 1,572
Global burden of alcoholic liver diseases
Rehm, J., Samokhvalov, A. V., & Shield, K. D. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.007 · Cited by 740
Slade, T., Chapman, C., Swift, W., Keyes, K., Tonks, Z., & Teesson, M. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011827 · Cited by 463
Grucza, R. A., Sher, K. J., Kerr, W. C., Krauss, M. J., Lui, C. K., McDowell, Y. E., Hartz, S., Virdi, G., & Bierut, L. J. (2018) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13859 · Cited by 433
Rathod, S. D., De Silva, M. J., Ssebunnya, J., Breuer, E., Murhar, V., Luitel, N. P., Medhin, G., Kigozi, F., Shidhaye, R., Fekadu, A., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162038 · Cited by 103 · cited 1×
“Even in countries with higher rates of AUD screening, there is underutilization of AUD pharmacotherapy and less adherence to guidelines (30,33).”
BackgroundCritical role of estrogen in the progression of chronic liver diseases
Ezhilarasan, D. (2020) · Hepatobiliary & Pancreatic Diseases International · doi:10.1016/j.hbpd.2020.03.011 · Cited by 96 · cited 1×
“Previous studies indicate that women have a reduced volume of alcohol distribution, less e ffi cient fi rst-pass metabolism, and estrogen-sensitized Kup ff er cells in the liver, all of which contribute to the accumulation of toxic aldehyde metabolite (9,10).”
BackgroundMushi, D., Francis, J. M., Moshiro, C., Hanlon, C., & Teferra, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.822791 · Cited by 21
Cited by
Danpanichkul, P., Díaz, L. A., Suparan, K., Tothanarungroj, P., Sirimangklanurak, S., Auttapracha, T., Blaney, H. L., Sukphutanan, B., Pang, Y., Kongarin, S., et al. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0835 · Cited by 85
“Our findings are in line with trends observed from the GBD 2019 study, 21,24 which highlighted the rising prevalence rates of ALD and alcohol-attributable primary liver cancer even while the prevalence rate of AUD declined.”
Self-citationDanpanichkul, P., Suparan, K., Kim, D., & Wijarnpreecha, K. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13010278 · Cited by 54
“There is increasing evidence highlighting a growing trend in both alcohol use and alcohol-associated liver disease [74,75].”
BackgroundSelf-citationDanpanichkul, P., Suparan, K., Ng, C. H., Dejvajara, D., Kongarin, S., Panpradist, N., Chaiyakunapruk, N., Muthiah, M. D., Chen, V. L., Huang, D. Q., et al. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101020 · Cited by 37
Self-citationMortality outcomes in individuals with MASLD versus MASLD and increased alcohol intake
Aboona, M. B., Danpanichkul, P., Chen, V. L., Rangan, P., Kim, D., Alkhouri, N., Fallon, M. B., Noureddin, M., Arab, J. P., & Wijarnpreecha, K. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16726 · Cited by 29
Self-citation
Metadata
- Authors
- Danpanichkul, P., Ng, C. H., Muthiah, M., Suparan, K., Tan, D. J. H., Duangsonk, K., Sukphutanan, B., Kongarin, S., Harinwan, N., Panpradist, N., Takahashi, H., Kawaguchi, T., Vichitkunakorn, P., Chaiyakunapruk, N., Nathisuwan, S., Huang, D., Arab, J. P., Noureddin, M., Mellinger, J. L., & Wijarnpreecha, K.
- Venue
- American Journal of Gastroenterology
- Published
- 2023-12-26
- Volume
- 119
- Issue
- 5
- Pages
- 893-909
- ISSN
- 0002-9270 (ISSN-L)
- 1572-0241
- OpenAlex
- W4390225149
- Cited by
- 36
- References
- 7
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women. https://app.cochat.ai/papers/10.14309/ajg.0000000000002642
- The paper
- Danpanichkul, P., Ng, C. H., Muthiah, M., Suparan, K., Tan, D. J. H., Duangsonk, K., Sukphutanan, B., Kongarin, S., Harinwan, N., Panpradist, N., Takahashi, H., Kawaguchi, T., Vichitkunakorn, P., Chaiyakunapruk, N., Nathisuwan, S., Huang, D., Arab, J. P., Noureddin, M., Mellinger, J. L., & Wijarnpreecha, K. (2024). From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated Liver Disease and Alcohol Use Disorder in Young Women. American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000002642
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.